Atlas Trials

Feasibility of a Method for Analysis of Alzheimer´s Disease Specific Proteins in Nasal Secretion

Clinical trial NCT05791552 · UNKNOWN

Trial details

NCT number
NCT05791552
Sponsor
Noselab GmbH
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Nasal SecretionAlzheimer DiseaseBrain Nose Interface
Start date
2022-02-15
Primary completion
2023-06-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.